Latest news with #ArunVerma
Yahoo
17-07-2025
- Business
- Yahoo
Fresenius Kabi Receives 2025 Premier Supplier Legacy Award
A Five-Time Winner, Fresenius Kabi is Cited for Operational Excellence LAKE ZURICH, Ill., July 17, 2025--(BUSINESS WIRE)--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has received the 2025 Supplier Legacy Award from Premier, Inc., a leading technology-driven healthcare performance improvement company. This marks the fifth time since 2015 Premier has recognized Fresenius Kabi USA with this award for operational excellence. Fresenius Kabi was recognized for its long-standing support of Premier members through exceptional local customer service and engagement, value creation through clinical excellence and a commitment to lower costs. Supplier Legacy Award winners are selected by Premier member committees and have a tenure of more than three years as a Premier contracted supplier. "This award recognizes the commitment to service, innovation and collaboration by thousands of Fresenius Kabi employees from across our company," said Arun Verma, President, Fresenius Kabi Region U.S. and Member of the Executive Leadership Team, Fresenius Kabi AG. "It's especially gratifying to receive this award from a customer whose members make up more than 4,350 U.S. hospitals and health systems." "Fresenius Kabi supports Premier members by offering products and services that help improve costs, quality and operations – and deliver overall value," said Bruce Radcliff, Senior Vice President of Supply Chain at Premier. "We're honored to recognize Fresenius Kabi as a Supplier Legacy Award recipient." The Supplier Legacy Award recipients were honored during Premier's annual Breakthroughs Conference & Exhibition (July 15-17, 2025). Premier has awarded Fresenius Kabi its Supplier Legacy Award in 2015, 2017, 2018, 2021, and now in 2025. In 2024, Premier also awarded Fresenius Kabi its Trailblazer Award, one of Premier's highest honors, recognizing a national Premier-contracted supplier that delivers innovative and scalable methods and technologies to accelerate clinical evidence into real-world practice. About Fresenius Kabi As a global health care company, Fresenius Kabi is Committed to Life. The company's products, technologies, and services are used for the therapy and care of patients with critical and chronic conditions. With more than 41,000 employees and present in more than 100 countries, Fresenius Kabi's expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients' nutritional status – notably as the only corporation offering both product groups. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is a global leader in supplying blood collection bags and devices, supporting blood banks and health care facilities worldwide. The company's I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to health care and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. In line with the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of health care. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing health care solutions on a global scale. For more information, please visit To learn about U.S. career opportunities at Fresenius Kabi, visit us at and follow us on LinkedIn and Facebook. View source version on Contacts Media contact Matt Kuhn (847) Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
17-07-2025
- Business
- Business Wire
Fresenius Kabi Receives 2025 Premier Supplier Legacy Award
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has received the 2025 Supplier Legacy Award from Premier, Inc., a leading technology-driven healthcare performance improvement company. This marks the fifth time since 2015 Premier has recognized Fresenius Kabi USA with this award for operational excellence. Share This marks the fifth time since 2015 Premier has recognized Fresenius Kabi USA with this award for operational excellence. Fresenius Kabi was recognized for its long-standing support of Premier members through exceptional local customer service and engagement, value creation through clinical excellence and a commitment to lower costs. Supplier Legacy Award winners are selected by Premier member committees and have a tenure of more than three years as a Premier contracted supplier. 'This award recognizes the commitment to service, innovation and collaboration by thousands of Fresenius Kabi employees from across our company,' said Arun Verma, President, Fresenius Kabi Region U.S. and Member of the Executive Leadership Team, Fresenius Kabi AG. 'It's especially gratifying to receive this award from a customer whose members make up more than 4,350 U.S. hospitals and health systems.' 'Fresenius Kabi supports Premier members by offering products and services that help improve costs, quality and operations – and deliver overall value,' said Bruce Radcliff, Senior Vice President of Supply Chain at Premier. 'We're honored to recognize Fresenius Kabi as a Supplier Legacy Award recipient.' The Supplier Legacy Award recipients were honored during Premier's annual Breakthroughs Conference & Exhibition (July 15-17, 2025). Premier has awarded Fresenius Kabi its Supplier Legacy Award in 2015, 2017, 2018, 2021, and now in 2025. In 2024, Premier also awarded Fresenius Kabi its Trailblazer Award, one of Premier's highest honors, recognizing a national Premier-contracted supplier that delivers innovative and scalable methods and technologies to accelerate clinical evidence into real-world practice. About Fresenius Kabi As a global health care company, Fresenius Kabi is Committed to Life. The company's products, technologies, and services are used for the therapy and care of patients with critical and chronic conditions. With more than 41,000 employees and present in more than 100 countries, Fresenius Kabi's expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients' nutritional status – notably as the only corporation offering both product groups. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is a global leader in supplying blood collection bags and devices, supporting blood banks and health care facilities worldwide. The company's I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to health care and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. In line with the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of health care. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing health care solutions on a global scale. For more information, please visit To learn about U.S. career opportunities at Fresenius Kabi, visit us at and follow us on LinkedIn and Facebook.
Yahoo
17-07-2025
- Business
- Yahoo
Fresenius Kabi Receives 2025 Premier Supplier Legacy Award
A Five-Time Winner, Fresenius Kabi is Cited for Operational Excellence LAKE ZURICH, Ill., July 17, 2025--(BUSINESS WIRE)--Fresenius Kabi, part of the global healthcare company Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has received the 2025 Supplier Legacy Award from Premier, Inc., a leading technology-driven healthcare performance improvement company. This marks the fifth time since 2015 Premier has recognized Fresenius Kabi USA with this award for operational excellence. Fresenius Kabi was recognized for its long-standing support of Premier members through exceptional local customer service and engagement, value creation through clinical excellence and a commitment to lower costs. Supplier Legacy Award winners are selected by Premier member committees and have a tenure of more than three years as a Premier contracted supplier. "This award recognizes the commitment to service, innovation and collaboration by thousands of Fresenius Kabi employees from across our company," said Arun Verma, President, Fresenius Kabi Region U.S. and Member of the Executive Leadership Team, Fresenius Kabi AG. "It's especially gratifying to receive this award from a customer whose members make up more than 4,350 U.S. hospitals and health systems." "Fresenius Kabi supports Premier members by offering products and services that help improve costs, quality and operations – and deliver overall value," said Bruce Radcliff, Senior Vice President of Supply Chain at Premier. "We're honored to recognize Fresenius Kabi as a Supplier Legacy Award recipient." The Supplier Legacy Award recipients were honored during Premier's annual Breakthroughs Conference & Exhibition (July 15-17, 2025). Premier has awarded Fresenius Kabi its Supplier Legacy Award in 2015, 2017, 2018, 2021, and now in 2025. In 2024, Premier also awarded Fresenius Kabi its Trailblazer Award, one of Premier's highest honors, recognizing a national Premier-contracted supplier that delivers innovative and scalable methods and technologies to accelerate clinical evidence into real-world practice. About Fresenius Kabi As a global health care company, Fresenius Kabi is Committed to Life. The company's products, technologies, and services are used for the therapy and care of patients with critical and chronic conditions. With more than 41,000 employees and present in more than 100 countries, Fresenius Kabi's expansive product portfolio focuses on providing access to high-quality and lifesaving medicines and technologies. In Biopharma, Fresenius Kabi offers cutting-edge biosimilars for autoimmune diseases and oncology. With leading market positions in Clinical Nutrition, a broad portfolio of enteral and parenteral products makes a distinct difference in patients' nutritional status – notably as the only corporation offering both product groups. In MedTech, the company provides vital infusion pumps, cell and gene therapy devices, disposables, and more. Fresenius Kabi is a global leader in supplying blood collection bags and devices, supporting blood banks and health care facilities worldwide. The company's I.V. Generics and Fluids for infusion therapy help save millions of lives every year, in emergency medicine, surgery, oncology, and intensive care. Fresenius Kabi takes a holistic approach to health care and uniquely combines experience, expertise, innovation, and dedication – making a difference in the lives of 450 million patients annually. In line with the #FutureFresenius strategy, the company is developing, producing, and selling new products and technologies and aspires to expand its position as a leading global provider of therapies, improve patient care, generate sustainable value for stakeholders – shaping the future of health care. Fresenius Kabi is an operating company of the Fresenius Group, founded in 1912, along with Helios and Quirónsalud. As ONE team, the companies in the Fresenius Group are committed to providing lifesaving and life-changing health care solutions on a global scale. For more information, please visit To learn about U.S. career opportunities at Fresenius Kabi, visit us at and follow us on LinkedIn and Facebook. View source version on Contacts Media contact Matt Kuhn (847)
BBC News
11-07-2025
- Sport
- BBC News
Will Elanga be 'quite frightening' with Isak?
BBC Nottingham presenter Arun Verma has given the lowdown on exactly what Newcastle fans should be expecting from winger Anthony Elanga, with his transfer to Tyneside set to be completed this week. "When Forest bought Anthony Elanga, they bought him as a bit of a raw talent. People had seen what he was capable of at Manchester United but it wasn't working for him," Verma said. "He needed to be coached, he needed to be understood a little bit more and he came to Forest, and he got given that opportunity. It was very similar to the Callum Hudson-Odoi situation of getting these players that people know are talented and saying 'come on, try and create your craft and hone it in and see what we can do'."Elanga arrived with bags of personality - frightening pace not only without the ball but with it as well - and not only that, he can finish, he can cross, he's got trickery in his locker but also, he doesn't know which foot is his best foot."So when you've got a player who can play on either flank, score with either foot, you have got someone that can cause a lot of problems. "You look at Chris Wood's goals from last year and a lot of that came from Elanga being able to split the lines so, it's quite frightening to think what he might be capable of doing with his Swedish counterpart [Alexander Isak] at Newcastle."Listen to the full chat on BBC Radio Newcastle Total Sport podcast
